Evidence map›Paper›PMID 33570634›Full record

ArticleBlood advances2021

Pre-HCT mosaicism increases relapse risk and lowers survival in acute lymphoblastic leukemia patients post-unrelated HCT.

Yiwen Wang, Weiyin Zhou, Junke Wang, Ezgi Karaesmen, Hancong Tang, Philip L McCarthy, Marcelo C Pasquini, Youjin Wang, Lisa J McReynolds, Hormuzd A Katki and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Yiwen WangCollege of Pharmacy, The Ohio State University, Columbus, OH.
Weiyin ZhouDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Junke WangCollege of Pharmacy, The Ohio State University, Columbus, OH.
Ezgi KaraesmenCollege of Pharmacy, The Ohio State University, Columbus, OH.
Hancong TangCollege of Pharmacy, The Ohio State University, Columbus, OH.
Philip L McCarthyDepartment of Medicine, Roswell Park Comprehensive Cancer Institute, Buffalo, NY.
Marcelo C PasquiniDepartment of Medicine, Medical College of Wisconsin, Milwaukee, WI.
Youjin WangDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Lisa J McReynoldsDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Hormuzd A KatkiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Mitchell J MachielaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Meredith YeagerDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Loreall PoolerDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA.
Xin ShengDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA.
Christopher A HaimanDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA.
David Van Den BergDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA.
Stephen R SpellmanCenter for International Blood and Marrow Transplant Research, Minneapolis, MN.
Tao WangCenter for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.
Michelle KuxhausenCenter for International Blood and Marrow Transplant Research, Minneapolis, MN.
Stephen J ChanockDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Stephanie J LeeCenter for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.
Alyssa I Clay-GilmourDepartment of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC; and.
Theresa E HahnDepartment of Medicine, Roswell Park Comprehensive Cancer Institute, Buffalo, NY.
Shahinaz M GadallaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Lara E Sucheston-CampbellCollege of Pharmacy, The Ohio State University, Columbus, OH.

Funding

Genetic EpidemiologyZIACP005803 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GOLDSTEIN, ALISA · 2009 to 2025
$24.8M
Genetic susceptibility to unrelated donor stem cell transplant-related mortalityR01HL102278 · NHLBI · ROSWELL PARK CANCER INSTITUTE CORP · PI HAHN, THERESA E, SUCHESTON-CAMPBELL, LARA · 2010 to 2013
$5.0M
NHLBI NIH HHS R01 HL102278
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MosaicismPrecursor Cell Lymphoblastic Leukemia-LymphomaHumansRecurrenceTransplantation, Homologous

Identifiers

PMID33570634
PMCPMC7805319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.